Stada Arz posts strong 1st-half 2016 earnings growth

4 August 2016
drugs_pills_tablets_big

German drugmaker Stada Arzneimittel (SAZ: Xetra) saw its share rise 1.35% to 48.26 euros in late morning trading today after it reported financial results, showing strong earnings growth.

Reported group sales showed a slight rise of 1% to 1,035 million euros. When effects on sales based on changes in the Group portfolio and currency effects are deducted, adjusted group salesincreased by 4% to 1,061 million euros.

Reported operating profit increased by 22% to 136.3 million euros in the first six months of 2016. Reported earnings before interest, taxes, depreciation and amortization (EBITDA) rose by 11% to 200.7 million euros. Reported net income increased by 53% to 82.0 million euros.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Generics